BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 32272980)

  • 1. Autoimmune bullous skin diseases, pemphigus and pemphigoid.
    Egami S; Yamagami J; Amagai M
    J Allergy Clin Immunol; 2020 Apr; 145(4):1031-1047. PubMed ID: 32272980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of autoimmune bullous diseases.
    van Beek N; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2018 Sep; 16(9):1077-1091. PubMed ID: 30179336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodiagnosis of pemphigus and mucous membrane pemphigoid.
    Challacombe SJ; Setterfield J; Shirlaw P; Harman K; Scully C; Black MM
    Acta Odontol Scand; 2001 Aug; 59(4):226-34. PubMed ID: 11570526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology and molecular diagnosis of autoimmune bullous diseases.
    Mihai S; Sitaru C
    J Cell Mol Med; 2007; 11(3):462-81. PubMed ID: 17521373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
    Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
    Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune bullous skin diseases].
    Joly P
    Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune blistering skin diseases: diagnostic and therapeutic approach].
    Hammers CM; Schmidt E; Zillikens D
    Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1473-7. PubMed ID: 24983196
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunofluorescence of Autoimmune Bullous Diseases.
    Diercks GF; Pas HH; Jonkman MF
    Surg Pathol Clin; 2017 Jun; 10(2):505-512. PubMed ID: 28477893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern diagnostics of autoimmune bullous diseases].
    van Beek N; Schumacher N; Rose C; Schmidt E; Zillikens D
    Pathologe; 2020 Jul; 41(4):317-325. PubMed ID: 32542511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
    Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
    Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 15. The desmosome and hemidesmosome in cutaneous autoimmunity.
    Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biological aspects of acquired bullous diseases.
    Dabelsteen E
    Crit Rev Oral Biol Med; 1998; 9(2):162-78. PubMed ID: 9603234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of bullous pemphigoid].
    Göbel M; Eming R
    Hautarzt; 2019 Apr; 70(4):236-242. PubMed ID: 30874841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
    Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
    Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
    Korman NJ; Stanley JR; Woodley DT
    Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.